Dr. King is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
513 Parnassus Ave
S-224
San Francisco, CA 94143Phone+1 415-476-2342Fax+1 415-476-0689
Summary
- Dr. King is Dean of the School of Medicine and Vice Chancellor-Medical Affairs at the University of California, San Francisco (UCSF).
Dr. King held the Julius R. Krevans Distinguished Professorship in Internal Medicine and was Chair of the Department of Medicine at UCSF. Prior to his appointment at UCSF, Dr. King was Professor of Medicine at the University of Colorado School of Medicine. He is a member of the National Academy Medicine (formerly the Institute of Medicine of the National Academy of Sciences), the American Academy of Arts and Sciences, the Association of American Physicians, the American Clinical and Climatological Association and the Fleischner Society. He is a Master of the American College of Physicians and a Fellow of the American College of Chest Physicians. He was a member of the Board of Directors of the National Committee for Quality Assurance; Board of Trustees of Gustavus Adolphus College; and Scientific Advisory Council, Doris Duke Charitable Foundation. He has served on the Advisory Council of the National Heart Lung and Blood Institute; Lung Biology and Pathology Study Section of the NIH; Pulmonary and Allergy Drugs Advisory Committee Center for Drug Evaluation & Research of the FDA; NIH Advisory Board for Clinical Research and the Board of Extramural Advisors of the National Heart Lung and Blood Institute. He is a past president of the American Thoracic Society (ATS) and Secretary/Treasurer of the American Board of Internal Medicine. His research interest is the pathogenesis, diagnosis and management of inflammatory and immunologic lung injury. His bibliography comprises more than 300 publications. He has co-edited 15 books, including the acclaimed reference books: Interstitial Lung Disease, (now in 5th edition); and Murray & Nadel’s Textbook of Respiratory Medicine (now in 7th ed. In press). He co-edited Medical Management of Vulnerable & Underserved Patients: Principles, Practice, Population (now in 2nd edition).
Education & Training
- University of ColoradoFellowship, Pulmonary Disease and Critical Care Medicine, 1977 - 1979
- Emory University School of MedicineResidency, Internal Medicine, 1974 - 1977
- Harvard Medical SchoolClass of 1974
Certifications & Licensure
- CA State Medical License 1997 - 2025
- CO State Medical License 1977 - 2017
- GA State Medical License 1975 - 1977
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Elected Member Institute of Medicine, 2004
- Whos Who in Medicine and Healthcare Marquis Whos Who
Clinical Trials
- Sildenafil Trial of Exercise Performance in Idiopathic Pulmonary Fibrosis Start of enrollment: 2007 Aug 01
- Evaluating the Effectiveness of Prednisone, Azathioprine, and N-acetylcysteine in Patients With IPF Start of enrollment: 2009 Oct 01
- AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis Start of enrollment: 2009 Oct 01
Publications & Presentations
PubMed
- 45 citationsA new era in idiopathic pulmonary fibrosis: considerations for future clinical trialsHarold R. Collard, Williamson Z. Bradford, Vincent Cottin, Kevin R. Flaherty, Talmadge E. King
The European Respiratory Journal. 2015-04-21 - 461 citationsIdiopathic pulmonary fibrosis: Relationship between histopathologic features and mortalityTalmadge E. King, Marvin I. Schwarz, Kevin K. Brown, Janet A. Tooze, Thomas V. Colby
American Journal of Respiratory and Critical Care Medicine. 2001-09-15 - 4037 citationsAn Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-Based Guidelines for Diagnosis and ManagementGanesh Raghu, Harold R. Collard, Jim J. Egan, Fernando J. Martinez, Juergen Behr
American Journal of Respiratory and Critical Care Medicine. 2011-03-15
Other
- Diagnosis and treatment of pulmonary alveolar proteinosis in adultsKing TE, Chan ED
http://www.uptodate.com/contents/diagnosis-and-treatment-of-pulmonary-alveolar-proteinosis-in-adults
UpToDate, Wolters Kluwer Health - 2012-05-04 - Basic principles and technique of bronchoalveolar lavageKing TE
http://www.uptodate.com/contents/basic-principles-and-technique-of-bronchoalveolar-lavage
UpToDate, Wolters Kluwer Health - 2012-05-11 - Interpretation of lung biopsy results in interstitial lung diseaseKing TE
http://www.uptodate.com/contents/interpretation-of-lung-biopsy-results-in-interstitial-lung-disease
UpToDate, Wolters Kluwer Health - 2012-05-07 - Join now to see all
Press Mentions
- Trump Could Still Be Infectious with the Coronavirus at the Next DebateOctober 6th, 2020
- Black History Month 2016: Reflecting on the Impact of RaceFebruary 23rd, 2016
Grant Support
- Idiopathic Pulmonary Fibrosis Clinical Research NetworkNational Heart, Lung, And Blood Institute2005–2009
- Role Of IFN Gamma And KGF In Human Pulmonary FibrosisNational Heart, Lung, And Blood Institute1997–2001
- Role Of Interferon And Keratinocyte Growth Factor In Human Pulmonary FibrosisNational Center For Research Resources1997
- Core--Clinical CoreNational Heart, Lung, And Blood Institute1992–1995
- Idiopathic Pulmonary Fibrosis--Pathogenesis And StagingNational Heart, Lung, And Blood Institute1987–1995
- Correlated Studies Of Pulmonary FibrosisNational Heart, Lung, And Blood Institute1986
- Immune Complexes And Neutrophils In Interstitial Lung DiseaseNational Heart, Lung, And Blood Institute1985–1986
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: